In order to obtain an authorisation, the sponsor shall submit an application dossier to the Member States concerned through the EU portal.
Home› Health & Pharmaceuticals› Clinical Trials Regulation
Chapter III · AUTHORISATION PROCEDURE FOR A SUBSTANTIAL MODIFICATION OF A CLINICAL TRIAL › Article 16
Submission of application
←→ also move between articles